Literature DB >> 9227172

Pericardial involvement in systemic sclerosis.

R J Byers1, D A Marshall, A J Freemont.   

Abstract

OBJECTIVE: To determine the frequency and histological characteristics of pericardial involvement in systemic sclerosis.
METHOD: Necropsy sections of pericardium from 44 patients with systemic sclerosis were studied, together with sections from 19 age/sex matched controls. Sections were stained with haematoxylin and eosin, acid toluidine blue, and elastic van Gieson. Mast cells were counted in 10 random high power fields and the degree of fibrosis was quantified using a Chalkley count.
RESULTS: Chronic pericarditis was seen in 31 (77.5%) of the systemic sclerosis cases, but in only one of the controls. The characteristic changes of uraemic pericarditis were not seen. The degree of fibrosis was greater in those with systemic sclerosis, though numbers of mast cells, thought to be important in fibrogenesis, were similar in both groups. Myocardial fibrosis was seen in 15 (37.5%) of systemic sclerosis cases but in none of the controls.
CONCLUSION: The incidence of pericarditis and myocardial fibrosis is much greater than in controls. The results indicate that pericarditis is a primary disease (rather than secondary to uraemia).

Entities:  

Mesh:

Year:  1997        PMID: 9227172      PMCID: PMC1752384          DOI: 10.1136/ard.56.6.393

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Cardiac tamponade as an initial manifestation of systemic lupus erythematosus.

Authors:  Diego M Carrion; Andres F Carrion
Journal:  BMJ Case Rep       Date:  2012-06-12

2.  Resolution of sclerodermatous myocarditis after autologous stem cell transplantation.

Authors:  M Al-mashaleh; H Bak; J Moore; N Manolios; H Englert
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

3.  New development of cardiac tamponade on underlying effusive-constrictive pericarditis: an uncommon initial presentation of scleroderma.

Authors:  Stalin R Subramanian; Rakhshanda Akram; Arash Velayati; Hal Chadow
Journal:  BMJ Case Rep       Date:  2013-07-12

4.  Pulmonary hypertension in polymyositis.

Authors:  Han Wang; Tao Liu; Ying-ying Cai; Lian Luo; Meng Wang; Mengmeng Yang; Lin Cai
Journal:  Clin Rheumatol       Date:  2015-10-14       Impact factor: 2.980

Review 5.  Cardiac tamponade and large pericardial effusions in systemic sclerosis: a report of four cases and a review of the literature.

Authors:  James V Dunne; Julie P Chou; Mohan Viswanathan; Pearce Wilcox; Simon H Huang
Journal:  Clin Rheumatol       Date:  2011-01-14       Impact factor: 2.980

Review 6.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

Review 7.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 8.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

9.  Possible role of adipocytokines in systemic sclerosis-associated small pericardial effusion.

Authors:  Angela Chialà; Cinzia Rotondo; Emanuela Praino; Dorotea Natuzzi; Fabio Cacciapaglia; Florenzo Iannone
Journal:  J Scleroderma Relat Disord       Date:  2018-03-19

10.  Cardiac manifestations of rheumatological conditions: a narrative review.

Authors:  Mohammad Bagher Owlia; Seyed Mohammad Yousof Mostafavi Pour Manshadi; Nafiseh Naderi
Journal:  ISRN Rheumatol       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.